Chronic remodeling pathology in grafts

Current Opinion in Immunology

Volumn 9, Issue 5, 1997, Pages 676-680

  Orosz, Charles G ^a   Pelletier, Ronald P ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; BLOOD VESSEL GRAFT; GRAFT REJECTION; PATHOLOGY; REVIEW; T LYMPHOCYTE;

EID: 0030666377     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80048-9     Document Type: Article

References (46)

1. Gjertson DW. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry. Terasaki P, Cecka M. Clinical Transplants 1992. 1993;299-317 UCLA Tissue Typing Laboratory, Los Angeles.
2. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 44:1993;411-422.
3. Solez K. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant. 8:1994;345-350.
4. Azuma H, Heemann UW, Tullius SG, Tilney NL. Cytokines and adhesion molecules in chronic rejection. Clin Transplant. 8:1994;168-180.
5. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. of special interest Transplant Rev. 10:1996;236-253 An excellent overview of chronic allograft rejection with a clinical perspective. The primary focus is on the vascular biology of ischernia/reperfusion injury and its effects on later events leading to chronic graft failure.
6. Orosz CG, Bergese SD, Wakely E, Xia D, Gordillo GM, Van Buskirk AM. Acute versus chronic graft rejection: related manifestations of allosensitization in graft recipients. Transplant Rev. 11:1997;38-50.
7. Lemstrom K, Koskinen P, Hayry P. Molecular mechanisms of chronic renal allograft rejection. Kidney Int. 48:1995;S2-S10. (suppl 52).
8. Azuma H, Tilney NL. Immune and nonimmune mechanisms of chronic rejection of kidney allografts. J Heart Lung Transplant. 14:1995;S136-S142.
9. Orosz CG, Sedmak DD. Concerns regarding the current paradigm for chronic allograft rejection. Trans Immunol. 1997;. in press.
10. Raines E, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 69:1993;530-537.
11. Hayry P, Mennander A, Raisanen-Sokolowski A, Ustinov J, Lemstrom K, Aho P, Yilmaz S, Lautenschlager I, Paavonen T. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev. 7:1993;1-20.
12. Kato Y, Periasamy M. Growth and differentiation of smooth muscle cells during vascular development. Trends Cardiovasc Med. 6:1996;100-106.
13. Yilmaz S, Paavonen T, Hayry P. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation. 53:1992;823-827.
14. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol. 152:1994;5135-5141.
15. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NES, Wyner LR, Kamovsky MJ. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 59:1995;572-578.
16. Adams DH, Wyner LR, Karnovsky MJ. Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development. Transplantation. 56:1993;794-799.
17. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. 1. Time course and immunogenetic and immunopathologicalal considerations. Am J Pathol. 144:1994;260-270.
18. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, Michel JB. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation. 60:1995;414-424.
19. Shi CW, Lee W-S, He Q, Zhang D, Fletcher DL Jr, Newell JB, Haber E. Immunologic basis of transplant-associated arteriosclerosis. of outstanding interest Proc Natl Acad Sci USA. 93:1996;4051-4056 A revealing series of studies conducted with mutant mouse strains that demonstrates the immunological conditions (i.e. requirements for macrophages, T cell subsets, etc.) necessary for rapid neointimal formation in carotid grafts.
20. Orosz CG. Networked alloimmunity: a brief reexamination of some basic concepts in transplantation immunobiology. of special interest J Heart Lung Transplant. 15:1996;1063-1068 A view of immunobiology that accepts complexity as an indispensable element of immune responses. This view suggests that many of the current experimental approaches may be fundamentally flawed because they either ignore complexity as a formative element, or they limit it so severely that the experimental outcomes lose their biological relevance.
21. Asahara T, Murohara T, Sullivan A, Silver M, Van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for anglogenesis. Science. 275:1997;964-967.
22. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1:1994;71-81.
23. Izutani H, Miyagawa S, Shirakura R, Matsumiya G, Nakata S, Shimazaki Y, Matsuda H. Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction: histopathologicalal analysis using a retransplantation model. Transplantation. 60:1995;1073-1079.
24. Schmid C, Heemann U, Tilney NL. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. of special interest Transplantation. 61:1996;1695-1699 These studies highlight the influence of peri-transplant trauma on vascular remodeling by demonstrating that retransplantation of cardiac isografts promotes the development of transplant vasculopathy that is as rapid and severe as that observed in the retransplantation of cardiac allografts.
25. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 16:1995;27-33.
26. Ferguson R. Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant. 8:1994;328-331.
27. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation. 57:1994;857-859.
28. Tullius SG, Hancock WW, Heemann UW. Long-term kidney isografts develop functional and morphological changes which mimic those of chronic allograft rejection. Ann Surg. 220:1994;425-432.
29. Davies MG, Hagen PO. Structural and functional consequences of bypass grafting with autologous vein. Cryobiology. 31:1994;63-70.
30. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study. Cell Tissue Res. 281:1995;421-433.
31. Waller BF, Orr CM, Van Tassel J, Peters T, Fry E, Hermiller J, Grider L. Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures. Part I. Clin Cardiol. 19:1996;744-748.
32. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. of special interest Transplantation. 63:1997;519-528 A definitive work demonstrating that chronic physiological insufficiency caused by reduced blood flow in rat kidneys can stimulate profound changes in organ function and architecture, including the development of chronic rejection-like histopathology.
33. Zhao X-M, Yeoh T-K, Hiebert M, Frist WH, Miller GG. The expression of acidic fibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. Transplantation. 56:1993;1177-1182.
34. Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathological role. Proc Natl Acad Sci USA. 92:1995;6547-6551.
35. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
36. Wagner CR, Morris TE, Shipley GD, Hosenpud JD. Regulation of human aortic endothelial cell-derived mesanchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest. 92:1993;1269-1277.
37. Goetzel EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. of special interest J Immunol. 156:1996;1-4 An excellent, brief review of matrix metalloproteinase production by T cells during inflammation and immunity.
38. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8:1994;823-831.
39. Nathan C, Sporn M. Cytokines in context. J Cell Biol. 113:1991;981-986.
40. Van den Eertwegh A, Boersma W, Claasen E. Immunological functions and in vivo cell-cell interactions of T cells in the spleen. Crit Rev Immunol. 11:1992;337-379.
41. Rose ML. Antibody-mediated rejection following cardiac transplantation. Transplant Rev. 7:1993;140-152.
42. Batiuk TD, Pazderka F, Halloran PF. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation. 59:1995;1400-1404.
43. Koskinen PK, Lernstrom KB, Hayry PJ. How cyclosporin modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol. 146:1995;972-980.
44. Geerling RA. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat. Transplantation. 58:1994;1258-1263.
45. Xiao F, Chong A, Shen J, Yang J, Short J, Foster P, Sankary H, Jensik S, Mital D, McChesney L, et al. Pharmacologically induced regression of chronic transplant rejection. Transplantation. 60:1995;1065-1072.
46. Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection. Effects of cyclosporine and donor antigen. Transplantation. 63:1997;1053-1058.